Craft

Endologix

Revenue

$143.4 M

FY, 2019

Endologix Summary

Company Summary

Overview
Endologix is a medical device company that provides therapies for the treatment of vascular disease. It offers abdominal stent grafts and endovascular systems to treat abdominal aortic aneurysms (AAA).
Type
Subsidiary
Status
Active
Founded
1992
HQ
Irvine, CA, US | view all locations
Website
http://www.endologix.com
Cybersecurity rating
Sectors

Key People

  • Cindy Pinto

    Cindy Pinto, Chief Financial Officer

    • Mike Mathias

      Mike Mathias, Chief Commercial Officer

      • Graham Phillips

        Graham Phillips, Chief Operating Officer

      • Christopher Leach

        Christopher Leach, Vice President, Sales Americas

      Operating MetricsView all

      Trademark Applications (US)

      2

      Jan, 2024

      Trademarks (US)

      16

      Jan, 2024

      LocationsView all

      4 locations detected

      • Irvine, CA HQ

        United States

        2 Musick

      • Milpitas, CA

        United States

        1971 Milmont Dr

      • Santa Rosa, CA

        United States

        3910 Brickway Blvd

      • 's-Hertogenbosch, NB

        Netherlands

        Utopialaan 33

      Endologix Financials

      Summary Financials

      Revenue (Q2, 2020)
      $24.8M
      Gross profit (Q2, 2020)
      $14.2M
      Net income (Q2, 2020)
      ($26.1M)
      Cash (Q2, 2020)
      $18.5M
      EBIT (Q2, 2020)
      ($17.3M)

      Footer menu